FDA Recalls Zinbryta®
FDA Recalls Zinbryta® after multiple cases of Encephalitis reported.
Zinbryta is a prescription drug intended for the treatment of Multiple Sclerosis (MS) which is a debilitating Autoimmune disease that attacks the victim’s nerve endings. That being said, the pain someone with MS goes through is excruciating, which has forced a large number of Americans to turn to the drug Zinbryta for relief but unfortunately, it has had the opposite effect.
Contact Experienced Attorney
In 2016, Zinbryta was approved by the FDA, but in 2018 the Food and Drug Administration began withdrawing that approval.
Due to recent reports of Encephalitis, or brain inflammation, the FDA is looking to recall Zinbryta from the US market. These reports include 12 specific cases of Encephalitis, three of which resulted in death.
Multiple Sclerosis is a terrible disease to deal with causing a range of sensations. This could include the feeling of pins and needles, numbness, burning, and crawling. Getting the right treatment can be hard to manage due to multiple effects. If you are currently taking Zinbryta, please consult with your doctor immediately, especially if you are suffering from strong headaches, which is a possible sign for Encephalitis.
- Moderate flu-like symptoms
- Loss of consciousness
- Muscle weakness
No person enduring the pain of MS should have to deal with adverse side effects caused by their prescription. If you or a loved one are taking Zinbryta to treat MS and are experiencing any unexpected effects, especially Encephalitis, please reach out to Schachter, Hendy, & Johnson at 859-578-4444 or contact us online. We believe patients deserve the best treatment and at SHJ we have years of experience winning claims for our clients. Please feel free to contact us today!